(Press-News.org) Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes.
The research is being led by Xavier Intes, Rensselaer professor of biomedical engineering and co-director of the Center for Modeling, Simulation and Imaging in Medicine, and Margarida Barroso, a professor of molecular and cellular physiology and director of the Imaging Core Facility at Albany Medical College. RPI and Albany Medical College have collaborated continuously for over a decade focusing on treatments to improve human health supported by six major grants. This grant propels that collaboration forward using modern AI tools.
Targeted drugs are an important part of many cancer therapies to improve specificity and reduce negative side effects. However, resistance to targeted therapy often occurs, preventing long-term, disease-free survival in many patients.
This grant will fund research in HER2-positive breast cancer where it has been proposed that intratumor heterogeneity (ITH), in which cells within the same tumor have different profiles, and microenvironmental factors play a key role in treatment failure. Hence, a better understanding of the underlying mechanisms of HER2 therapy resistance and their relationship with ITH, as well as with the host and tumor microenvironments, is essential for the development of new strategies to improve patient outcomes.
Preclinical longitudinal, non-invasive imaging approaches that can dissect and quantify heterogeneities at the level of multiple tumor features such as drug-HER2 engagement, glucose metabolic levels, and vasculature are lacking. Currently, these parameters can only be assessed through ex-vivo invasive means, using tissue removed from and then returned to the patient.
“Through our research, we will develop a novel mesoscopic, multimodal preclinical imaging approach to test the hypothesis that the distribution of antibody-based therapeutics across tumors mediates not only drug efficacy but also the advent of tumor resistance,” said Intes.
The team will use mesoscopic fluorescence molecular tomography (MFMT) to dissect tumor heterogeneities at near cellular scale resolution in live, intact animals.
Barroso will also collaborate with Sandra Shin, MD, chair of the Department of Pathology and Laboratory Medicine at Albany Medical Center, to correlate histopathology with these novel optical imaging approaches.
“Ultimately, we hope this imaging technology will allow biologists and clinicians to see exactly how a drug binds to a tumor, providing a better understanding of how tumors adapt or change during treatment,” said Barroso. “This could help determine a particular drug’s efficacy on a specific tumor, a key element of tackling drug resistance.”
“For more than a decade, NCI has been recognizing the importance of this cross-institutional collaboration and the unique skills and expertise each researcher brings to the collaboration,” added Alan S. Boulos, MD, ’94, The Lynne and Mark Groban, MD ’67 Dean of Albany Medical College. “The studies supported by this new grant will have a significant impact on the future of cancer diagnostics and therapy.”
“Breast cancer is such a prevalent disease that we all know someone affected by it,” said Shekhar Garde, dean of Rensselaer’s School of Engineering. “I am pleased that Drs. Intes and Barroso are combining the power of engineering and medicine with modern artificial intelligence tools to advance our understanding of this particularly virulent form and improve patients’ quality of life.”
About Rensselaer Polytechnic Institute
Founded in 1824, Rensselaer Polytechnic Institute is America’s first technological research university. Rensselaer encompasses five schools, over 30 research centers, more than 140 academic programs including 25 recent programs, and a dynamic community made up of over 6,800 students and 104,000 living alumni. Rensselaer faculty and alumni include upward of 155 National Academy members, six members of the National Inventors Hall of Fame, six National Medal of Technology winners, five National Medal of Science winners, and a Nobel Prize winner in Physics. With nearly 200 years of experience advancing scientific and technological knowledge, Rensselaer remains focused on addressing global challenges with a spirit of ingenuity and collaboration. To learn more, please visit www.rpi.edu.
About Albany Medical Center
Albany Medical Center, northeastern New York’s only academic medical center, is one of the largest private employers in the Capital Region. It incorporates the 766-bed Albany Medical Center, which offers the widest range of medical and surgical services in the region, and Albany Medical College, which trains the next generation of doctors, scientists, and other healthcare professionals. It also includes the region’s largest physicians’ practice with 500 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life. Albany Medical Center is a member of the Albany Med Health System, which also includes Columbia Memorial Health, Glens Falls Hospital, Saratoga Hospital, and the Visiting Nurses. The region’s largest locally governed health system, it has 1,520 beds, more than 800 physicians and 125 outpatient locations throughout the Capital Region.
RPI Contact:
Katie Malatino
Sr. Communications Specialist
malatk@rpi.edu
838-240-5691
Albany Medical Center Contact:
Cassie Nelson
Manager of Communications
nelsonc6@amc.edu
518-262-3421
###
END
Led by Kelly Chipps of the Department of Energy’s Oak Ridge National Laboratory, scientists working in the lab have produced a signature nuclear reaction that occurs on the surface of a neutron star gobbling mass from a companion star. Their achievement improves understanding of stellar processes generating diverse nuclear isotopes.
“Neutron stars are really fascinating from the points of view of both nuclear physics and astrophysics,” said ORNL nuclear astrophysicist Kelly Chipps, who led a study published in Physical Review Letters. “A deeper understanding of their dynamics may help reveal the cosmic ...
Programme of combined one-to-one and group support sessions was tested in landmark clinical trial
After one year, one in five people were able to stop taking opioids without their pain increasing
Experts say the new treatment is an alternative to opioid use and has potential to give patients better quality of life
Researchers at the University of Warwick and The James Cook University Hospital, Middlesbrough have led a clinical trial, funded by the National Institute for Health and Care Research (NIHR), on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain.
There are over 1 ...
CHICAGO ---CT scans are better at predicting a middle-aged person’s risk for a heart disease, such as a heart attack, than genetics, reports a new Northwestern Medicine study.
“Finding the best way to identify who is at risk for developing heart disease can help determine what needs to be done to lower their risk,” said lead study author Dr. Sadiya Khan, an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine cardiologist. “This finding can help doctors and patients in managing risk for heart disease, which is the leading cause ...
Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.
Their findings on the condition called degenerative mitral regurgitation were published today in the peer-reviewed Journal of the American Medical Association (JAMA), representing the largest study to date that examines outcomes for patients treated outside of a clinical trial with transcatheter edge-to-edge repair (TEER).
“Treatment was successful in nearly nine out of every 10 patients in whom TEER was used to repair ...
WASHINGTON, May 23, 2023 – Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily injections to avoid peripheral diseases caused by extremes of high or low blood sugar.
Automated insulin delivery systems, also called artificial pancreases, make diabetes management much less onerous for patients. These systems — with implanted insulin sensors, pumps that ...
WASHINGTON, May 23, 2023 – Volatile organic compounds are chemicals emitted as gases that can have adverse health effects. They are often found in paints, pharmaceuticals, and refrigerants, among other common products, but they can also act as markers of explosives, insect infestation, food spoilage, and disease.
Tracing VOCs is important for public safety and all “smell” related issues. To this end, in Applied Physics Reviews, from AIP Publishing, Liu et al. introduced a fluid mechanics-based chamber design for an electronic nose (e-nose) that consistently detects ...
bout The Study: In this study of women living in low-income areas, those who moved to a higher-income area between births experienced less morbidity and death in their second pregnancy, as did their newborns, compared with those who remained in low-income areas between births. Research is needed to determine whether financial incentives or enhancement of neighborhood factors can reduce adverse maternal and perinatal outcomes.
Authors: Joel G. Ray, M.D., M.Sc., of the University of Toronto, is the corresponding author.
To ...
About The Study: Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease in this study that included 2,300 vaccinated health care workers in Israel.
Authors: Gili Regev-Yochay, M.D., of the Sheba Medical Center in Ramat Gan, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.14757)
Editor’s ...
About The Study: The findings in this study of nearly 1,700 midlife women without diabetes suggest that prediabetes was associated with risk of fracture. Future research should determine whether treating prediabetes reduces fracture risk.
Authors: Albert Shieh, M.D., of the David Geffen School of Medicine at University of California, Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.14835)
Editor’s ...
About The Study: The results of this quality improvement study involving 13,000 nursing homes suggest widespread underreporting of major injury falls and pressure ulcers, and underreporting was associated with the racial and ethnic composition of a facility. Alternative approaches to measuring quality need to be considered.
Authors: Prachi Sanghavi, Ph.D., of the University of Chicago, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.14822)
Editor’s Note: Please see the article for additional information, including other ...
